Login
Search
Search
0 Dates
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Refining Genetic Prediction in Dilated Cardiomyopathy: Evaluating the Madrid Score and Enhanced Machine Learning Models with Clinical and Imaging Data
Session:
SESSÃO DE POSTERS 18 - MIOCARDIOPATIA DILATADA
Speaker:
Inês Miranda
Congress:
CPC 2025
Topic:
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
Theme:
17. Myocardial Disease
Subtheme:
17.3 Myocardial Disease – Diagnostic Methods
Session Type:
Cartazes
FP Number:
---
Authors:
Inês Pereira de Miranda; Carolina Pereira Mateus; Filipa Gerardo; Mara Sarmento; Rodrigo Brandão; Mariana Passos; Inês Fialho; Ana Oliveira Soares; David Roque; João Bicho Augusto
Abstract
<p style="text-align:justify"><span style="font-size:14px"><span style="font-family:Arial,Helvetica,sans-serif"><span style="color:#000000"><strong>Background:</strong> Investigating dilated cardiomyopathy (DCM) etiology in clinical practice is challenging, especially when selecting patients who benefit from genetic testing. In 2022 Madrid Score was created to help predict patients who are likely to have <span style="background-color:white">pathogenic or likely pathogenic (P/LP) genetic variants. </span></span></span></span></p> <p style="text-align:justify"><span style="font-size:14px"><span style="font-family:Arial,Helvetica,sans-serif"><span style="color:#000000"><strong>Objective:</strong> We aimed to evaluate the Madrid Score's applicability in a real-world population of DCM patients.</span></span></span></p> <p style="text-align:justify"><span style="font-size:14px"><span style="font-family:Arial,Helvetica,sans-serif"><span style="color:#000000"><strong>Methods:</strong> We conducted a single-center, retrospective study evaluating 137 DCM patients who underwent genetic testing between 2018 and 2024. Data collected included demographics, clinical history, imaging parameters (echocardiogram and cardiac MRI), and genetic testing results (gene negative, variant of uncertain significance [VUS], or P/LP variant). The Madrid Score (variables include family history of DCM, skeletal muscle disease, left bundle branch block, low QRS voltage in limb leads, hypertension) was calculated for all patients. Logistic regression models were developed to evaluate Madrid Score's predictive power, with additional clinical and imaging variables tested to enhance predictions. Advanced machine learning models, including Gradient Boosting, were also tested. Performance metrics such as accuracy, precision, recall, F1 score, and area under the receiver operating characteristic curve (AUC) were calculated. Feature importance analysis was performed on the Gradient Boosting model to identify key predictors. The dataset was manually oversampled to address class imbalance in patients with P/LP variants.</span></span></span></p> <p style="text-align:justify"><span style="font-size:14px"><span style="font-family:Arial,Helvetica,sans-serif"><span style="color:#000000"><strong>Results:</strong> Of 119 suitable patients (mean age 60±13 years, 65% male), 55.5% were gene positive - 46.2% VUS, 9.3% P/LP (TTN was the most common gene). Patients with P/LP mutations had significantly higher Madrid Scores than those with VUS or no mutation (35.5±19.6 vs. 33.3±19.6 vs. 30.6±19.1; p=0.03). Logistic regression confirmed the Madrid Score as an independent P/LP mutation predictor (odds ratio per unit increase: 1.03; 95% CI: 1.01–1.06; p=0.03) with moderate discriminatory ability (AUC=0.67). Logistic regression </span>incorporating<span style="color:#000000"> clinical and imaging features showed limited performance (AUC=0.43, accuracy=70.6%, recall=66.7%, precision=57.1%). </span> In contrast, t<span style="color:#000000">he Gradient Boosting model </span>significantly <span style="color:#000000">outperformed others, achieving AUC=0.91, accuracy=85.3%, recall=86.7%, and precision=81.3%. Feature importance analysis </span>revealed<span style="color:#000000"> age, left ventricular ejection fraction, and LV end-diastolic volume as top predictors above the Madrid Score.</span></span></span></p> <p style="text-align:justify"><span style="font-size:14px"><span style="font-family:Arial,Helvetica,sans-serif"><span style="color:#000000"><strong>Conclusions:</strong> The Madrid Score is a useful predictor of P/LP genetic variants in DCM, but its discriminatory ability is moderate. Advanced machine learning models integrating clinical and imaging data significantly improve predictive accuracy. These findings highlight the potential of combining data-driven approaches to enhance genetic testing yield, though further validation is needed.</span></span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site